[1]
“Sotorasib: A Targeted Breakthrough in KRAS G12C- Mutated Non-Small Cell Lung Cancer”, Int. J. Res. Pharm. Sci. Technol., vol. 9, no. 3, Aug. 2026, doi: 10.33974/7tt6d117.